Trypanosoma cruzi Response to Sterol Biosynthesis Inhibitors: Morphophysiological Alterations Leading to Cell Death

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kessler, Rafael Luis ^a   Soares, Maurilio José ^a   Probst, Christian Macagnan ^a   Krieger, Marco Aurélio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; KETOCONAZOLE; MEVINOLIN; RHODAMINE 123;

ARTICLE; AUTOPHAGY; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL ORGANELLE; CELL PROLIFERATION; CELL STRUCTURE; CELL SWELLING; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; CYTOSOL; DEPOLARIZATION; DRUG EXPOSURE; EPIMASTIGOTE; FLOW CYTOMETRY; GROWTH INHIBITION; MITOCHONDRIAL DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PARASITE EXAMINATION; PARASITE VIABILITY; PHENOTYPE; RESERVOSOME; STEROL SYNTHESIS; TRYPANOSOMA CRUZI;

BIOSYNTHETIC PATHWAYS; CELL DEATH; CHAGAS DISEASE; ENZYME INHIBITORS; KETOCONAZOLE; LOVASTATIN; MITOCHONDRIA; PERMEABILITY; STEROLS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84873136488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055497     Document Type: Article

References (97)

1. Rassi A Jr, Rassi A, Marin-Neto JA, (2010) Chagas disease. Lancet 375: 1388-1402.
2. Coura JR, Dias JC, (2009) Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 104 Suppl 1: 31-40.
3. Wilkinson SR, Kelly JM, (2009) Trypanocidal drugs: mechanisms, resistance and new targets. Expert Rev Mol Med 11: e31.
4. Camargo EP, (2009) Perspectives of vaccination in Chagas disease revisited. Mem Inst Oswaldo Cruz 104 Suppl 1: 275-280.
5. Dumonteil E, (2009) Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era. Infect Genet Evol 9: 1075-1082.
6. Urbina JA, (2010) Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 115: 55-68.
7. Urbina JA, (2009) Ergosterol biosynthesis and drug development for Chagas disease. Mem Inst Oswaldo Cruz 104 Suppl 1: 311-318.
8. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, et al. (2003) Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol 126: 129-142.
9. Urbina JA, Vivas J, Visbal G, Contreras LM, (1995) Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol Biochem Parasitol 73: 199-210.
10. Liendo A, Visbal G, Piras MM, Piras R, Urbina JA, (1999) Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes. Mol Biochem Parasitol 104: 81-91.
11. de Souza W, Rodrigues JC, (2009) Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdiscip Perspect Infect Dis 2009: 642502.
12. Buckner FS, (2008) Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections. Adv Exp Med Biol 625: 61-80.
13. Ghannoum MA, Rice LB, (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517.
14. Urbina JA, Lazardi K, Aguirre T, Piras MM, Piras R, (1988) Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 32: 1237-1242.
15. McCabe RE, Remington JS, Araujo FG, (1984) Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. J Infect Dis 150: 594-601.
16. Beach DH, Goad LJ, Holz GG Jr, (1986) Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes. Biochem Biophys Res Commun 136: 851-856.
17. McCabe R, (1988) Failure of ketoconazole to cure chronic murine Chagas' disease. J Infect Dis 158: 1408-1409.
18. Brener Z, Cancado JR, Galvao LM, da Luz ZM, Filardi Lde S, et al. (1993) An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem Inst Oswaldo Cruz 88: 149-153.
19. Liendo A, Lazardi K, Urbina JA, (1998) In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J Antimicrob Chemother 41: 197-205.
20. Urbina JA, Lazardi K, Aguirre T, Piras MM, Piras R, (1991) Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 35: 730-735.
21. Urbina JA, Lira R, Visbal G, Bartroli J, (2000) In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 44: 2498-2502.
22. Urbina JA, Payares G, Contreras LM, Liendo A, Sanoja C, et al. (1998) Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 42: 1771-1777.
23. Urbina JA, Payares G, Sanoja C, Lira R, Romanha AJ, (2003) In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int J Antimicrob Agents 21: 27-38.
24. Urbina JA, Payares G, Sanoja C, Molina J, Lira R, et al. (2003) Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int J Antimicrob Agents 21: 39-48.
25. Urbina JA, Payares G, Molina J, Sanoja C, Liendo A, et al. (1996) Cure of short- and long-term experimental Chagas' disease using D0870. Science 273: 969-971.
26. Molina J, Martins-Filho O, Brener Z, Romanha AJ, Loebenberg D, et al. (2000) Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother 44: 150-155.
27. Endo A, (1992) The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res 33: 1569-1582.
28. Florin-Christensen M, Florin-Christensen J, Garin C, Isola E, Brenner RR, et al. (1990) Inhibition of Trypanosoma cruzi growth and sterol biosynthesis by lovastatin. Biochem Biophys Res Commun 166: 1441-1445.
29. Urbina JA, Lazardi K, Marchan E, Visbal G, Aguirre T, et al. (1993) Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 37: 580-591.
30. Hurtado-Guerrrero R, Pena-Diaz J, Montalvetti A, Ruiz-Perez LM, Gonzalez-Pacanowska D, (2002) Kinetic properties and inhibition of Trypanosoma cruzi 3-hydroxy-3-methylglutaryl CoA reductase. FEBS Lett 510: 141-144.
31. Concepcion JL, Gonzalez-Pacanowska D, Urbina JA, (1998) 3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties. Arch Biochem Biophys 352: 114-120.
32. Contreras VT, Araujo-Jorge TC, Bonaldo MC, Thomaz N, Barbosa HS, et al. (1988) Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media. Mem Inst Oswaldo Cruz 83: 123-133.
33. Sanz-Rodriguez CE, Concepcion JL, Pekerar S, Oldfield E, Urbina JA, (2007) Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies. J Biol Chem 282: 12377-12387.
34. Ameisen JC, Idziorek T, Billaut-Mulot O, Loyens M, Tissier JP, et al. (1995) Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival. Cell Death Differ 2: 285-300.
35. Kosec G, Alvarez VE, Aguero F, Sanchez D, Dolinar M, et al. (2006) Metacaspases of Trypanosoma cruzi: possible candidates for programmed cell death mediators. Mol Biochem Parasitol 145: 18-28.
36. Soares MJ, de Souza W, (1991) Endocytosis of gold-labeled proteins and LDL by Trypanosoma cruzi. Parasitol Res 77: 461-468.
37. Porto-Carreiro I, Attias M, Miranda K, De Souza W, Cunha-e-Silva N, (2000) Trypanosoma cruzi epimastigote endocytic pathway: cargo enters the cytostome and passes through an early endosomal network before storage in reservosomes. Eur J Cell Biol 79: 858-869.
38. Giusti C, Luciani MF, Klein G, Aubry L, Tresse E, et al. (2009) Necrotic cell death: From reversible mitochondrial uncoupling to irreversible lysosomal permeabilization. Exp Cell Res 315: 26-38.
39. Medina-Acosta E, Cross GA, (1993) Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure. Mol Biochem Parasitol 59: 327-329.
40. Guerra-Slompo EP, Probst CM, Pavoni DP, Goldenberg S, Krieger MA, et al. (2012) Molecular characterization of the Trypanosoma cruzi specific RNA binding protein TcRBP40 and its associated mRNAs. Biochem Biophys Res Commun.
41. de Souza W, Sant'Anna C, Cunha-e-Silva NL, (2009) Electron microscopy and cytochemistry analysis of the endocytic pathway of pathogenic protozoa. Prog Histochem Cytochem 44: 67-124.
42. Docampo R, Scott DA, Vercesi AE, Moreno SN, (1995) Intracellular Ca2+ storage in acidocalcisomes of Trypanosoma cruzi. Biochem J 310 (Pt 3):: 1005-1012.
43. Braga MV, Magaraci F, Lorente SO, Gilbert I, de Souza W, (2005) Effects of inhibitors of Delta24(25)-sterol methyl transferase on the ultrastructure of epimastigotes of Trypanosoma cruzi. Microsc Microanal 11: 506-515.
44. Braga MV, Urbina JA, de Souza W, (2004) Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents 24: 72-78.
45. Lazardi K, Urbina JA, de Souza W, (1990) Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 34: 2097-2105.
46. Lazardi K, Urbina JA, de Souza W, (1991) Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 35: 736-740.
47. Santa-Rita RM, Lira R, Barbosa HS, Urbina JA, de Castro SL, (2005) Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis. J Antimicrob Chemother 55: 780-784.
48. Vivas J, Urbina JA, de Souza W, (1997) Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by delta(24(25)) sterol methyl transferase inhibitors and their combinations with ketoconazole. Int J Antimicrob Agents 8: 1-6.
49. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, et al. (2010) Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141: 656-667.
50. Golstein P, Kroemer G, (2007) Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 32: 37-43.
51. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11.
52. Worthen C, Jensen BC, Parsons M, (2010) Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei. PLoS Negl Trop Dis 4: e678.
53. Gee KR, Brown KA, Chen WN, Bishop-Stewart J, Gray D, et al. (2000) Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium 27: 97-106.
54. Fernandes MP, Inada NM, Chiaratti MR, Araujo FF, Meirelles FV, et al. (2010) Mechanism of Trypanosoma cruzi death induced by Cratylia mollis seed lectin. J Bioenerg Biomembr 42: 69-78.
55. Grijalba MT, Vercesi AE, Schreier S, (1999) Ca2+-induced increased lipid packing and domain formation in submitochondrial particles. A possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry 38: 13279-13287.
56. Bruchhaus I, Roeder T, Rennenberg A, Heussler VT, (2007) Protozoan parasites: programmed cell death as a mechanism of parasitism. Trends Parasitol 23: 376-383.
57. Assuncao Guimaraes C, Linden R, (2004) Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem 271: 1638-1650.
58. Urbina JA, Vivas J, Ramos H, Larralde G, Aguilar Z, et al. (1988) Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole. Mol Biochem Parasitol 30: 185-195.
59. Contreras LM, Vivas J, Urbina JA, (1997) Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors. Biochem Pharmacol 53: 697-704.
60. Vannier-Santos MA, De Castro SL, (2009) Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill. Curr Drug Targets 10: 246-260.
61. Johnson LV, Walsh ML, Bockus BJ, Chen LB, (1981) Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol 88: 526-535.
62. Rodrigues JC, Bernardes CF, Visbal G, Urbina JA, Vercesi AE, et al. (2007) Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition. Protist 158: 447-456.
63. John GB, Shang Y, Li L, Renken C, Mannella CA, et al. (2005) The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell 16: 1543-1554.
64. Pena-Diaz J, Montalvetti A, Flores CL, Constan A, Hurtado-Guerrero R, et al. (2004) Mitochondrial localization of the mevalonate pathway enzyme 3-hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae. Mol Biol Cell 15: 1356-1363.
65. Rodrigues CO, Catisti R, Uyemura SA, Vercesi AE, Lira R, et al. (2001) The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization. J Eukaryot Microbiol 48: 588-594.
66. Lepesheva GI, Hargrove TY, Anderson S, Kleshchenko Y, Furtak V, et al. (2010) Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi. J Biol Chem 285: 25582-25590.
67. Soares MJ, De Souza W, (1988) Cytoplasmic organelles of trypanosomatids: a cytochemical and stereological study. J Submicrosc Cytol Pathol 20: 349-361.
68. Cunha-e-Silva N, Sant'Anna C, Pereira MG, Porto-Carreiro I, Jeovanio AL, et al. (2006) Reservosomes: multipurpose organelles? Parasitol Res 99: 325-327.
69. Sant'Anna C, Parussini F, Lourenco D, de Souza W, Cazzulo JJ, et al. (2008) All Trypanosoma cruzi developmental forms present lysosome-related organelles. Histochem Cell Biol 130: 1187-1198.
70. Sant'Anna C, Nakayasu ES, Pereira MG, Lourenco D, de Souza W, et al. (2009) Subcellular proteomics of Trypanosoma cruzi reservosomes. Proteomics 9: 1782-1794.
71. Alvarez VE, Kosec G, Sant'Anna C, Turk V, Cazzulo JJ, et al. (2008) Autophagy is involved in nutritional stress response and differentiation in Trypanosoma cruzi. J Biol Chem 283: 3454-3464.
72. Andrade-Neto VV, Cicco NN, Cunha-Junior EF, Canto-Cavalheiro MM, Atella GC, et al. (2011) The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis. Acta Trop.
73. Herman M, Gillies S, Michels PA, Rigden DJ, (2006) Autophagy and related processes in trypanosomatids: insights from genomic and bioinformatic analyses. Autophagy 2: 107-118.
74. Edinger AL, Thompson CB, (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16: 663-669.
75. Perez-Sala D, Mollinedo F, (1994) Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun 199: 1209-1215.
76. Reedquist KA, Pope TK, Roess DA, (1995) Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells. Biochem Biophys Res Commun 211: 665-670.
77. Padayatty SJ, Marcelli M, Shao TC, Cunningham GR, (1997) Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab 82: 1434-1439.
78. Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, et al. (1998) Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res 58: 76-83.
79. Rubins JB, Greatens T, Kratzke RA, Tan AT, Polunovsky VA, et al. (1998) Lovastatin induces apoptosis in malignant mesothelioma cells. Am J Respir Crit Care Med 157: 1616-1622.
80. Ho YS, Tsai PW, Yu CF, Liu HL, Chen RJ, et al. (1998) Ketoconazole-induced apoptosis through P53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines. Toxicol Appl Pharmacol 153: 39-47.
81. Lin KL, Huang CC, Cheng JS, Tsai JY, Lu YC, et al. (2009) Ketoconazole-induced JNK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicol In Vitro 23: 1268-1276.
82. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, et al. (2008) Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135: 1311-1323.
83. Moreno SN, Docampo R, (2003) Calcium regulation in protozoan parasites. Curr Opin Microbiol 6: 359-364.
84. Laporte C, Kosta A, Klein G, Aubry L, Lam D, et al. (2007) A necrotic cell death model in a protist. Cell Death Differ 14: 266-274.
85. Lee SB, Bae IH, Bae YS, Um HD, (2006) Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J Biol Chem 281: 36228-36235.
86. Minamikawa T, Williams DA, Bowser DN, Nagley P, (1999) Mitochondrial permeability transition and swelling can occur reversibly without inducing cell death in intact human cells. Exp Cell Res 246: 26-37.
87. Menna-Barreto RF, Correa JR, Pinto AV, Soares MJ, de Castro SL, (2007) Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone. Parasitol Res 101: 895-905.
88. Dantas AP, Salomao K, Barbosa HS, De Castro SL, (2006) The effect of Bulgarian propolis against Trypanosoma cruzi and during its interaction with host cells. Mem Inst Oswaldo Cruz 101: 207-211.
89. Yamashima T, (2004) Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 36: 285-293.
90. Yamashima T, (2000) Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62: 273-295.
91. Syntichaki P, Xu K, Driscoll M, Tavernarakis N, (2002) Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419: 939-944.
92. Berghe TV, Vanlangenakker N, Parthoens E, Deckers W, Devos M, et al. (2010) Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 17: 922-930.
93. Johansson AC, Appelqvist H, Nilsson C, Kagedal K, Roberg K, et al. (2010) Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 15: 527-540.
94. Trosken ER, Adamska M, Arand M, Zarn JA, Patten C, et al. (2006) Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. Toxicology 228: 24-32.
95. Lamb DC, Kelly DE, Baldwin BC, Kelly SL, (2000) Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents. Chem Biol Interact 125: 165-175.
96. Laverriere M, Cazzulo JJ, Alvarez VE, (2012) Antagonic activities of Trypanosoma cruzi metacaspases affect the balance between cell proliferation, death and differentiation. Cell Death Differ 19: 1358-1369.
97. Golstein P, Kroemer G, (2005) Redundant cell death mechanisms as relics and backups. Cell Death Differ 12 Suppl 2: 1490-1496.